1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
- 2023
-
Mark
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
APOE -ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
(
- Contribution to journal › Article
- 2022
-
Mark
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
(
- Contribution to journal › Article
-
Mark
Quantification of amyloid PET for future clinical use : a state-of-the-art review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
(
- Contribution to journal › Article
- 2020
-
Mark
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load
(
- Contribution to journal › Article
- 2018
-
Mark
Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
(
- Contribution to journal › Article
-
Mark
Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
(
- Contribution to journal › Article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article